These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11175308)

  • 1. Fusagene vectors: a novel strategy for the expression of multiple genes from a single cistron.
    Gäken J; Jiang J; Daniel K; van Berkel E; Hughes C; Kuiper M; Darling D; Tavassoli M; Galea-Lauri J; Ford K; Kemeny M; Russell S; Farzaneh F
    Gene Ther; 2000 Dec; 7(23):1979-85. PubMed ID: 11175308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-2/B7.1 (CD80) fusagene transduction of AML blasts by a self-inactivating lentiviral vector stimulates T cell responses in vitro: a strategy to generate whole cell vaccines for AML.
    Chan L; Hardwick N; Darling D; Galea-Lauri J; Gäken J; Devereux S; Kemeny M; Mufti G; Farzaneh F
    Mol Ther; 2005 Jan; 11(1):120-31. PubMed ID: 15585413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tricistronic viral vectors co-expressing interleukin-12 (1L-12) and CD80 (B7-1) for the immunotherapy of cancer: preclinical studies in myeloma.
    Wen XY; Mandelbaum S; Li ZH; Hitt M; Graham FL; Hawley TS; Hawley RG; Stewart AK
    Cancer Gene Ther; 2001 May; 8(5):361-70. PubMed ID: 11477456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient cotransduction of tumors by multiple herpes simplex vectors: implications for tumor vaccine production.
    Karpoff HM; Kooby D; D'Angelica M; Mack J; Presky DH; Brownlee MD; Federoff H; Fong Y
    Cancer Gene Ther; 2000 Apr; 7(4):581-8. PubMed ID: 10811476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of bicistronic retroviral vectors containing internal ribosome entry sites (IRES) using expression of human interleukin-12 (IL-12) as a readout.
    Harries M; Phillipps N; Anderson R; Prentice G; Collins M
    J Gene Med; 2000; 2(4):243-9. PubMed ID: 10953915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advantages and limitations of particle-mediated transfection (gene gun) in cancer immuno-gene therapy using IL-10, IL-12 or B7-1 in murine tumor models.
    Kitagawa T; Iwazawa T; Robbins PD; Lotze MT; Tahara H
    J Gene Med; 2003 Nov; 5(11):958-65. PubMed ID: 14601133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple combination of oncolytic herpes simplex virus-1 vectors armed with interleukin-12, interleukin-18, or soluble B7-1 results in enhanced antitumor efficacy.
    Ino Y; Saeki Y; Fukuhara H; Todo T
    Clin Cancer Res; 2006 Jan; 12(2):643-52. PubMed ID: 16428511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status.
    Douin-Echinard V; Bornes S; Rochaix P; Tilkin AF; Peron JM; Bonnet J; Favre G; Couderc B
    Cancer Gene Ther; 2000 Dec; 7(12):1543-56. PubMed ID: 11228533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity.
    Todo T; Martuza RL; Dallman MJ; Rabkin SD
    Cancer Res; 2001 Jan; 61(1):153-61. PubMed ID: 11196154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful immunogene therapy using colon cancer cells (colon 26) transfected with plasmid vector containing mature interleukin-18 cDNA and the Igkappa leader sequence.
    Yoshimura K; Hazama S; Iizuka N; Yoshino S; Yamamoto K; Muraguchi M; Ohmoto Y; Noma T; Oka M
    Cancer Gene Ther; 2001 Jan; 8(1):9-16. PubMed ID: 11219497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feline B7.1 and B7.2 proteins produced from swinepox virus vectors are natively processed and biologically active: potential for use as nonchemical adjuvants.
    Winslow BJ; Kalabat DY; Brown SM; Cochran MD; Collisson EW
    Vet Microbiol; 2005 Nov; 111(1-2):1-13. PubMed ID: 16181751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of hepatocellular carcinoma by transfecting interleukin-12 and interleukin-2 fusion gene intrasplenically, an experimental study].
    Yang JH; Fan RF; Qian QJ; You TG; Xue HB; Su CQ; Cao HF; Wu MC
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):740-3. PubMed ID: 12899748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioactive murine and human interleukin-12 fusion proteins which retain antitumor activity in vivo.
    Lieschke GJ; Rao PK; Gately MK; Mulligan RC
    Nat Biotechnol; 1997 Jan; 15(1):35-40. PubMed ID: 9035103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model.
    Lee YS; Kim JH; Choi KJ; Choi IK; Kim H; Cho S; Cho BC; Yun CO
    Clin Cancer Res; 2006 Oct; 12(19):5859-68. PubMed ID: 17020994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of allelic expression patterns of IL-2, IL-3, IL-4, and IL-13 in human CD4+ T cell clones.
    Bayley JP; Bakker AM; Kaijzel EL; Wierenga EA; van der Pouw-Kraan TC; Huizinga TW; Verweij CL
    Eur J Immunol; 2003 Aug; 33(8):2142-8. PubMed ID: 12884288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of antitumor immunity against B16 melanoma tumor using genetically modified dendritic cells to produce cytokines.
    Akiyama Y; Watanabe M; Maruyama K; Ruscetti FW; Wiltrout RH; Yamaguchi K
    Gene Ther; 2000 Dec; 7(24):2113-21. PubMed ID: 11223993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy.
    Stagg J; Wu JH; Bouganim N; Galipeau J
    Cancer Res; 2004 Dec; 64(24):8795-9. PubMed ID: 15604233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-21 triggers both cellular and humoral immune responses leading to therapeutic antitumor effects against head and neck squamous cell carcinoma.
    Nakano H; Kishida T; Asada H; Shin-Ya M; Shinomiya T; Imanishi J; Shimada T; Nakai S; Takeuchi M; Hisa Y; Mazda O
    J Gene Med; 2006 Jan; 8(1):90-9. PubMed ID: 16097036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent antitumor effects of CD154 transduced tumor cells in experimental bladder cancer.
    Loskog A; Björkland A; Brown MP; Korsgren O; Malmström PU; Tötterman TH
    J Urol; 2001 Sep; 166(3):1093-7. PubMed ID: 11490305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-modification of IL-2-TNF alpha fusion gene and B7.1 gene to murine breast tumor cells leads to improved tumor rejection and vaccine effect.
    Liu X; Zhang L; Zhang M; Ma Y; Xu X; Cai Y
    Chin Med J (Engl); 2000 Feb; 113(2):167-71. PubMed ID: 11775545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.